Profile data is unavailable for this security.
About the company
Shouyao Holdings Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main business is the research and development of small molecule innovative drugs in the clinical stage. The Company's main products include anaplastic lymphoma kinase (ALK) kinase inhibitors, selective inhibitors and others. The Company's pharmaceutical products are used in key tumor indications such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, thyroid cancer, ovarian cancer, and leukemia, as well as disease areas such as type II diabetes. The Company mainly operates in the domestic market.
- Revenue in CNY (TTM)5.23m
- Net income in CNY-191.79m
- Incorporated2016
- Employees185.00
- LocationShouyao Holdings Co LtdBEIJING 100195ChinaCHN
- Phone+86 1 088857906
- Fax+86 1 088853760
- Websitehttp://www.shouyaoholding.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.33bn | -95.04m | 6.43bn | 1.05k | -- | 3.63 | -- | 2.76 | -0.1335 | -0.1335 | 3.22 | 2.48 | 0.553 | 16.07 | 2.29 | 2,220,525.00 | -2.31 | -2.92 | -4.78 | -5.30 | 22.41 | 28.14 | -4.18 | -5.77 | 1.22 | -0.3232 | 0.5063 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| Cisen Pharmaceutical Co Ltd | 4.48bn | 528.35m | 6.46bn | 3.40k | 12.26 | 1.10 | -- | 1.44 | 1.16 | 1.16 | 9.86 | 13.02 | 0.6082 | 2.81 | 5.65 | 1,315,959.00 | 7.21 | 6.94 | 9.02 | 8.56 | 57.33 | 56.27 | 11.85 | 10.77 | 3.12 | -- | 0.0373 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Beijing Foyou Pharma Co Ltd | 3.32bn | 507.64m | 6.58bn | 3.44k | 12.91 | 1.87 | -- | 1.98 | 1.06 | 1.06 | 6.95 | 7.35 | 0.7482 | 3.46 | 9.58 | 967,165.90 | 11.50 | -- | 14.81 | -- | 65.14 | -- | 15.37 | -- | 2.99 | -- | 0.0316 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
| Harbin Pharmaceutical Group Co., Ltd. | 15.67bn | 449.71m | 6.63bn | 9.85k | 14.39 | 1.35 | -- | 0.4232 | 0.1827 | 0.1827 | 6.34 | 1.95 | 1.13 | 6.35 | 3.46 | 1,590,093.00 | 3.79 | 0.7414 | 10.20 | 1.89 | 26.30 | 23.87 | 3.35 | 0.7294 | 1.06 | 40.41 | 0.393 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
| Shouyao Holdings Co Ltd | 5.23m | -191.79m | 6.67bn | 185.00 | -- | 6.89 | -- | 1,274.99 | -1.29 | -1.29 | 0.0352 | 6.51 | 0.0045 | 0.2644 | 5.25 | 28,265.68 | -16.55 | -37.24 | -18.01 | -42.63 | 96.50 | 96.03 | -3,667.74 | -2,251.77 | 8.49 | -- | 0.0018 | -- | 186.18 | -23.51 | -6.76 | -- | 34.59 | -- |
| Wuhan Keqian Biology Co Ltd | 989.49m | 347.63m | 6.95bn | 923.00 | 19.93 | 1.78 | -- | 7.02 | 0.748 | 0.748 | 2.12 | 8.37 | 0.213 | 1.93 | 3.03 | 1,072,036.00 | 7.47 | 13.29 | 8.81 | 15.49 | 68.82 | 76.49 | 35.09 | 45.71 | 3.65 | -- | 0.0508 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
Data as of Jun 25 2024. Currency figures normalised to Shouyao Holdings Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
29.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 6.75m | 12.42% |
| China Fund Management Co., Ltd.as of 31 Dec 2023 | 2.37m | 4.36% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023 | 1.40m | 2.57% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 1.24m | 2.29% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.15m | 2.12% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 1.05m | 1.94% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 846.34k | 1.56% |
| ABC-CA Fund Management Co., Ltd.as of 31 Dec 2023 | 613.73k | 1.13% |
| Golden Eagle Asset Management Co., Ltd.as of 31 Dec 2023 | 567.88k | 1.05% |
| Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 282.79k | 0.52% |
More ▼
Data from 31 Dec 2023 - 17 Jun 2024Source: FactSet Research Systems Inc.
